myelopeptide 1 has been researched along with thymic factor, circulating in 2 studies
| Studies (myelopeptide 1) | Trials (myelopeptide 1) | Recent Studies (post-2010) (myelopeptide 1) | Studies (thymic factor, circulating) | Trials (thymic factor, circulating) | Recent Studies (post-2010) (thymic factor, circulating) |
|---|---|---|---|---|---|
| 179 | 4 | 2 | 234 | 12 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khait, OV; Tumasyan, KP; Zaporozhan, VN | 1 |
| Bulava, GV; Nikulina, VP | 1 |
2 other study(ies) available for myelopeptide 1 and thymic factor, circulating
| Article | Year |
|---|---|
Norcolut with immune modulators in the complex treatment for hyperplastic uterine processes.
Topics: Activins; Adjuvants, Immunologic; Adult; Drug Combinations; Endometrial Hyperplasia; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Injections, Intramuscular; Luteinizing Hormone; Menstruation; Norethindrone; Oligopeptides; Peptides; Progesterone; Thymus Hormones | 1993 |
[Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications].
Topics: Activins; Adjuvants, Immunologic; Bone Marrow; Empyema, Pleural; Humans; Immunoglobulins; Lymphocyte Subsets; Oligopeptides; Osteomyelitis; Peptides; Peritonitis; Phagocytosis; Postoperative Complications; Suppuration; Surgical Wound Infection; Thymus Extracts; Thymus Hormones; Time Factors | 1996 |